Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : MLSC Blood decontaminant recieves patent!!! -- Ignore unavailable to you. Want to Upgrade?

To: Dr. Bob who wrote (153)	6/10/1998 11:02:00 AM
From: Cindy Powell	Read Replies (1) \| Respond to of 196

Tuesday June 9, 6:22 pm Eastern Time Company Press Release SOURCE: Medical Discoveries, Inc. Medical Discoveries, Inc. Announces Management Additions, Promotions LAYTON, Utah, June 9 /PRNewswire/ -- Medical Discoveries, Inc. (OTC Bulletin Board: MLSC - news) focused on the research, development and commercialization of electrolysis based products targeted at anti-bacterial, anti-fungal and anti-viral (HIV/AIDS) applications, announced today the following additions and promotions. Scott R. Wood, CPA has been named Chief Financial Officer. Since 1995, Mr. Wood has served as the Company's Financial Advisor. Mr. Wood received his MBA from Brigham Young University in 1980, and was awarded his Certified Public Accountant Certificate in 1983. Since April of 1997, Mr. Wood has worked closely with MDI's Senior Management team in strategic planning and development, and has been closely involved in the recent joint venture and other business development projects. Neal G. Ofiesh has been named National Sales Director for newly created MDI HealthCare Systems division. Mr. Ofiesh has been actively engaged in the sales, distribution and management of sales activities for a number of companies in the field of water purification systems, cosmetics and related consumer products. In this newly created position, Mr. Ofiesh will provide the Company with proven expertise in establishing a national distribution network for the Company's consumer targeted products. Prior to joining the Company, Mr. Ofiesh was affiliated with the MeLaLeuca, Natural World and NSA corporations. Osao Sumita, Ph.D. has joined MDI Team Japan, as Senior Director Engineering and Technology Development. Dr. Sumita has spent over 20 years in research and development in the field of electrolysis and related technologies. Since 1992 he has been president and founder of Coherent Technologies (Tokyo, Japan) a research and development firm specializing in the development of proprietary electrolysis technology systems. Dr. Sumita received his Doctorate from the Tokyo Institute of Technology, Tokyo, Japan, and is the holder of several patents in the field of electrolysis. In this newly created position, Dr. Sumita will be responsible for technology development and related research activities. William J. Novick, Jr., Ph.D. Chief Technical Officer has been promoted to Vice President and will become an Officer of the Company. Troy Fullmer, Manager Marketing Research, has been promoted to Director of Market Research. ''These additions and promotions strengthens the Company and rewards individuals whose efforts have positioned MDI for growth into revenue producing markets. MDI will pursue those markets and applications where our technologies provide the opportunities to improve quality of life and offer strong profit potential,'' stated President and CEO, Lee F. Kulas. SOURCE: Medical Discoveries, Inc.

To: Dr. Bob who wrote (153)	6/11/1998 1:57:00 PM
From: Cindy Powell	Read Replies (1) \| Respond to of 196

Greetings Dr. Bob, Kerry and all, Dr. Bob, yes, I do know a little bit about Lee Kulas' background. (From SEC filing May 15, 1997) MDI announced the appointment of Lee F. Kulas as President, Chief Executive Officer and Director. Mr. Kulas has over 20 years' of broad-based experience in management, marketing, sales and international business development, and has served as chief executive of two medical device start-up companies. He was most recently associated with K. K. Adachi (Osaka, Japan) as president and chief executive officer of Adachi's U.S. operations. Founder and former CEO of Applied Vascular Engineering, Inc. (Nasdaq: AVEI), Kulas has also held marketing and sales positions with the Cordis Corporation (now a division of Johnson & Johnson), Mallinckrodt Interventional Cardiology, the Puritan Bennett Corp. and C.R. Bard. As an international business development consultant with special emphasis on Europe and Japan, Kulas spearheaded the establishment of United States operations for two foreign medical products companies. The driving force behind 23 major product introductions, Kulas piloted the "user design team" concept and has supervised clinical research, regulatory submissions and product development activities domestically and in Canada, Europe and Japan. He is named on one patent and two patents pending. Medical Discoveries is holding it's own! Profit taking has not resulted in as much volatility as I would have expected. Congratulations to Medical Discoveries and MLSC shareholders! News of these leaps and bounds in progress for Medical Discoveries has been more than exciting! Todays news was particularly tell-tale of good faith in the potential for MDI-P. I look forward to many more happy returns. Best wishes to all, Cindy